NALPROPION Trademark

Trademark Overview


On Friday, June 15, 2018, a trademark application was filed for NALPROPION with the United States Patent and Trademark Office. The USPTO has given the NALPROPION trademark a serial number of 88002407. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 7, 2025. This trademark is owned by Nalpropion Pharmaceuticals, Inc.. The NALPROPION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of obesity and inducing weight loss

General Information


Serial Number88002407
Word MarkNALPROPION
Filing DateFriday, June 15, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 7, 2025
Registration Number5735425
Registration DateTuesday, April 23, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of obesity and inducing weight loss

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 7, 2025
Primary Code005
First Use Anywhere DateFriday, May 25, 2018
First Use In Commerce DateMonday, October 15, 2018

Trademark Owner History


Party NameNALPROPION PHARMACEUTICALS LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBrentwood, TN 37027

Party NameNalpropion Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Party NameNalpropion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Party NameNalpropion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Trademark Events


Event DateEvent Description
Tuesday, June 19, 2018NEW APPLICATION ENTERED
Thursday, June 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 3, 2018ASSIGNED TO EXAMINER
Tuesday, October 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 15, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 22, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, February 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 22, 2019USE AMENDMENT FILED
Tuesday, February 12, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, March 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 23, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 23, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 23, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 7, 2025CANCELLED SEC. 8 (6-YR)